)
Enanta Pharmaceuticals (ENTA) investor relations material
Enanta Pharmaceuticals Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for March 11, 2026, to be held virtually for shareholders of record as of January 16, 2026.
Proxy materials, including the notice, proxy statement, and annual report, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of two Class I directors to serve until the 2029 annual meeting or until successors are qualified.
Approval of an amendment to the 2019 Equity Incentive Plan.
Advisory vote on executive compensation for named executive officers.
Ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2026.
Board recommends voting for all director nominees and all proposals.
Board of directors and corporate governance
Board recommends the election of Bruce L.A. Carter, Ph.D., and Jay R. Luly, Ph.D., as Class I directors.
- TimeTickerHeadlineOpen
- IMKTA
Strong sales and profit growth, improved margins, and lower debt highlight the quarter. - AGCO
2025 sales fell 13.5%, but margins and cash flow hit records; 2026 outlook is stable. - LHB
Net profit reached SEK 502m, with strong lending growth and robust capital ratios. - ASTRAL
Q3 FY26 delivered 17% volume growth, 18.2% EBITDA margin, and strong multi-segment expansion. - 531768
Q3 FY26 revenue and profit rose strongly YoY, supported by global expansion and steady margins. - AURIONPRO
26% revenue growth, strong margins, major wins, and AI-driven expansion mark the period. - 513023
Net profit rose 83.5% QoQ to ₹325.7 Cr, driven by strong energy and mining results. - APOTEA
Q4 revenue rose 7% but margins fell; full-year growth strong, driven by Rx and new investments. - HSY
2026 outlook targets 4%-5% sales growth, margin recovery, and 30%-35% EPS growth. - MTSI
Revenue up 24.5% year-over-year, with strong margins and positive Q2 outlook.
Next Enanta Pharmaceuticals earnings date
Next Enanta Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)